- Daiichi Sankyo, Inc. (Bernards, NJ)
- …to help people. Under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on ... and immune disorders.Summary The Senior Director sits within Global Oncology Clinical Development, an organization dedicated to the effective strategy, design,… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily ... review), Statistical Analysis Plan (SAP), Statistical Analysis, Results Interpretation, and clinical study report (CSR): Executes statistical activities for low to… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …that communicates clinical , economic, and value-based attributes of Mitsubishi Tanabe Pharma US therapies to key payer segments and channels. + Travel with the ... **Overview** **Entrepreneurial Spirit, Rooted in Tradition** . Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a US subsidiary of Mitsubishi Tanabe Pharma … more
- Mitsubishi Chemical Group (Jersey City, NJ)
- **Overview** **Entrepreneurial Spirit, Rooted in Tradition** . Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a US subsidiary of Mitsubishi Tanabe Pharma ... markets. In the United States, MTPA launched rare disease treatments including RADICAVA( R ) (edaravone) injectables in 2017 and RADICAVA( R ) (edaravone) oral… more
